• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Fighting for Patients, Processes and Education

by MM360 Staff | May 6, 2025 | Uncategorized

Source: CureToday articles I would like to nominate Ashley Tullio, RN, for the Extraordinary Healer Award for Oncology Nursing. Read More

Immune Therapy Expands Melanoma Treatment to More Patients

by MM360 Staff | May 6, 2025 | Uncategorized

Source: CureToday articles Immune therapy is generally safer than chemotherapy, allowing more patients with melanoma and other conditions like heart or lung issues receive treatment. Read More

The Importance of Personalized Treatment Approaches for Urologic Cancers

by MM360 Staff | May 6, 2025 | Uncategorized

Source: CureToday articles Dr. Armine Smith discusses the importance of personalized therapeutic approaches for the treatment of urologic cancers, such as bladder or kidney cancer. Read More

Nurse’s Big Personality Makes Cancer Treatment More Bearable.

by MM360 Staff | May 6, 2025 | Uncategorized

Source: CureToday articles She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled. Read More

Givinostat Wins U.S. FDA Fast Track Designation for Patients With PV

by MM360 Staff | May 6, 2025 | Uncategorized

Source: CureToday articles Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for patients with polycythemia vera. Read More

First Patient With Advanced Lung Cancer Dosed With Peluntamig Combo

by MM360 Staff | May 6, 2025 | Uncategorized

Source: CureToday articles The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas. Read More
« Older Entries
Next Entries »

Recent Content

  • 1st trial participant receives Alpha DaRT radiation therapy for glioblastoma
  • (no title)
  • New targeted cancer therapy IDE034 heading to Phase 1 clinical trial
  • (no title)
  • Tecvayli-Darzalex Faspro combo up for approval in 2 nations for treating RRMM
  • In vivo CAR-T exhibits activity in advanced multiple myeloma
  • FDA backs faster development of new therapy for hard-to-treat AML
  • The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
  • Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy
  • Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT